---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-21-025336"
form_type: "8-K"
ticker: "PBYI"
cik: "0001401667"
company_name: "PUMA BIOTECHNOLOGY, INC."
filed_at: "2021-11-04T23:59:59+00:00"
generated_at: "2026-06-28T12:47:22.357267+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Puma Biotechnology enters into $50M at-the-market equity distribution agreement with Jefferies

## Summary
- Up to $50M of common stock may be sold from time to time in ATM offerings through Jefferies LLC.
- Jefferies receives 3% commission on gross proceeds; sales at prevailing market prices.
- Company has no obligation to sell any shares under the agreement.
- Shares offered under existing shelf registration statement (File No. 333-257687) effective July 13, 2021.
- Agreement may remain effective until July 2024 unless earlier terminated.

## SEC filing metadata
- accession: 0001437749-21-025336
- form_type: 8-K
- ticker: PBYI
- cik: 0001401667
- company_name: PUMA BIOTECHNOLOGY, INC.
- filed_at: 2021-11-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1401667/000143774921025336/0001437749-21-025336-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1401667/000143774921025336/pbyi20211104_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-21-025336
- JSON: https://secwatch.observer/filing/0001437749-21-025336.json
- Plain text: https://secwatch.observer/filing/0001437749-21-025336.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.